Inovio to present at upcoming scientific conferences

Plymouth meeting, pa. , april 9, 2025 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-related diseases, cancer, and infectious diseases, today announced that it will highlight key data associated with its lead candidate, ino-3107, at several upcoming conferences, including an opportunity to join other leading voices at the inaugural national hpv conference.
INO Ratings Summary
INO Quant Ranking